US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, BAR ILAN UNIVERSITY on June 2 for "Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications" (Israeli Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,867, issued on June 2, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Jerusalem) and BAR ILAN UNIVERSITY (Ramat Gan, Israel).

"Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications" was invented by Itamar Willner (Mevasseret Zion, Israel), Sharon Etery (Rishon le Tzion, Israel), Yossi Mandel (Givataim, Israel), Amos Markus (Petah Tikva, Israel) and Asaf Shoval (Raanana, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an antiangiogenic agent in the form of a vehicle, e.g., a nanopart...